medigraphic.com
ISSN 1729-519X (Print)

2015, Number 6

<< Back Next >>

Revista Habanera de Ciencias Médicas 2015; 14 (6)

Characterization of non-palpable breast lesions

Concepción QL, Rodríguez DY, Campos VO

Language: Spanish
References: 22
Page: 747-759
PDF size: 432.75 Kb.


ABSTRACT

Introduction: a great advance in management and prognostic of breast cancer is the early detection represented by non-palpable breast lesions.
Objective: characterize the non-palpable breast lesions in the Service of General Surgery at the "Enrique Cabrera" Hospital from February of 2009 to February of 2014.
Material and Methods: it was carried out an observational, descriptive and prospective study. The sample constituted by 65female patients who had nonpalpable breast lesions and classified according to Breast Imaging Reporting and Data System1993. The studied variables were: age, mammographic and anatomicopathological findings. To sum up, percent and absolute frequencies were used for statistical analysis and Chi-Square of Pearson test with significance of 0,05. The malignant incidence was calculates according to Relative risk (RR) and Odd Ratio (OR) with confidence interval (IC) 95%.
Results: there were 1366 patients under screening, 65 of them had non-palpable breast lesions, 18 (27,7%) malignant lesions and 47 (72,3%) benign lesions. A major illness was found within 50 - 64 year old group. Twenty five nodules were found tightly associated with breast cancer (36%), 31 micro calcifications, both association seven and two patients with distortion of mammary structure. The ductal carcinoma was the most frequent neoplasm (72,2%).
Conclusions: screen is a safety option for early diagnostic of non-palpable breast lesions.


REFERENCES

  1. Camacho R, Rubio MC, Rodríguez R, Pérez I, Valdés Z, Sánchez I. Guía de diagnóstico y tratamiento de Cáncer de Mama. Versión Electrónica. Rev. Chilena de Cirugía.Enero 2007.

  2. Camacho N, Barriga C, Osorio V, Lobo G, Capetillo F. Lesiones no palpables de mama: Resultados de biopsias radioquirúrgicas. Rev. Chilena de Cirugía. 2002; 54(2): 139-42.

  3. Rosenquist J, Lindfos K. Screening mammography beginning at age 40 years. Cáncer.1998; 82: 2235-40.

  4. Gotzsche P, Olsen O. Is screening for breast cancer with mammography justifiable. Lancet. 2000; 355: 129-34.

  5. Cruzcaya Ochoa M. Correlación ecográfica e histológica de lesiones mamarias identificadas en mamografía con clasificación BIRADS en pacientes que acuden al centro de atención ambulatoria del IESS de la ciudad de Loja, enero a diciembre 2009. Tesis para la obtención del título de especialista en Radiología e Imagen. Loja, Ecuador: 2011.

  6. American College of Radiology. BI-RADS®. Sistema de informes y registro de datos de imagen de mama. Reston VA: ACR; 2003. (Ed. esp.) Madrid: SERAM; 2006.

  7. Kalager M, Adami H-O, Bretthauer M. Too much mammography. BMJ. 2014; 348:1403.

  8. Ferrini R, Malur S, Wurdinger S. Comparison of written reports of mammography, sonography and magnetic resonance mammography for preoperative evaluation of breast lesions, with special emphasis on magnetic resonance mammography. Breast Cancer Res. 2011; 3:55-60.

  9. Welch HG, Passow HJ. Quantifying the benefits and harms of screening mammography. JAMA Int Med. 2013 Dec 30.

  10. León A, Camacho J, Baeza R, et al. Microcalcificaciones mamarias. Estudioretrospectivo de 13 años. Rev Chil Cir. 2010; 50: 290-3.

  11. Liberman L. Clinical management issues in percutaneous core breast biopsy. RadiolClin North Am. 2000; 38:791-807.

  12. Baljit S. Pathology of breast disorder. In Surgery of the Breast. Principles and Art. Third Edition. Editor Scott L. Spear. Lippincott Williams & Wilkins. 2011; (5):48- 61.

  13. KlimbergSV. Intraoperative Ultrasound-Guided Excision of Nonpalpable Lesions, In Breast surgery / edited by Kirby I. Bland, V. Suzanne Klimberg. Philadelphia, USA: Lippincott Williams & Wilkins. 2011:(8):131-146.

  14. Microcalcificaciones mamarias, Rev. chil. obstet. ginecol. Santiago. oct. 2013;78 (5).

  15. Weldon Hoque L. Pathology, Prognosis and Staging of Breast Cancer. In Breast Diseases, edited by Patrick I. Borgen and Arnold D.K. Hill., Landes Bioscience. Georgetown, Texas U.S.A.: 2010;(5): 88-99.

  16. Liberman L, Abramson AF, Squires FB, et al. The Breast Imaging Reporting and Data System: positive predictive value of mammographic features and final assessment categories. AJR. 2009; 171:35-40.

  17. Palomares-Vargas N. Características familiares, factores de riesgo y principales motivos de atención en la consulta externa. Rev Esp Méd Quir. 2012; 17(3):157-163.

  18. Bleyer A, Welch HG. Effect of three decades of screening mammography on breast-cancer incidence. N Engl J Med. 2012; 367:1998-2005.

  19. Consenso Nacional Inter-Sociedades sobre Cáncer de Mama. Pautas para el Diagnóstico y Manejo de las Lesiones Mamarias Subclínicas. Buenos Aires. Argentina: 2006.

  20. Vega Bolívar A. Intervencionismo diagnóstico en patología de mama. Rev. de Radiología. España: 2011; 53(6):531-543.

  21. Tran PV, Lui PC, Yu AM, Vinh PT, Chau HH, Ma TK, et al. Atypia in fine needle aspirates of breast lesions. J Clin Pathol. 2010; 63:585-91.

  22. Feig BW, Berger DH, Fuman GM. Anderson MD. Oncología. 2da edición. 2000;37:13-37.




2020     |     www.medigraphic.com